Abbott Drug Patent Portfolio
Abbott owns 3 orange book drugs protected by 12 US patents Given below is the list of Abbott's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5648497 | Retroviral protease inhibiting compounds | 15 Jan, 2015 | Expired |
| US5635523 | Retroviral protease inhibiting compounds | 03 Dec, 2014 | Expired |
| US5648497 | Retroviral protease inhibiting compounds | 15 Jul, 2014 | Expired |
| US5635523 | Retroviral protease inhibiting compounds | 03 Jun, 2014 | Expired |
| US5948436 | Pharmaceutical composition | 13 Mar, 2014 | Expired |
| US5541206 | Retroviral protease inhibiting compounds | 30 Jan, 2014 | Expired |
| US5948436 | Pharmaceutical composition | 13 Sep, 2013 | Expired |
| US5541206 | Retroviral protease inhibiting compounds | 30 Jul, 2013 | Expired |
| US5294615 | Terazosin polymorph and pharmaceutical composition | 29 Apr, 2013 | Expired |
| US5412095 | Terazosin monohydrochloride and processes and intermediate for its production | 29 Apr, 2013 | Expired |
| US5436272 | Treatment of obesity | 25 Jan, 2013 | Expired |
| US5436272 | Treatment of obesity | 25 Jul, 2012 | Expired |
Latest Legal Activities on Abbott's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Abbott.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent | 21 Oct, 2024 | US8268349 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 May, 2024 | US8268349 |
| Expire Patent | 16 May, 2022 | US8691878 |
| Maintenance Fee Reminder Mailed | 29 Nov, 2021 | US8691878 |
|
Expire Patent
Critical
| 02 Aug, 2021 | US8470347 (Litigated) |
|
Expire Patent
Critical
| 26 Apr, 2021 | US8399015 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 Feb, 2021 | US8470347 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 09 Nov, 2020 | US8399015 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Mar, 2020 | US7432294 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Feb, 2020 | US8268349 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 May, 2018 | US7148359 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2017 | US8691878 |
| Post Issue Communication - Certificate of Correction | 14 Jul, 2015 | US8691878 |
| Mail O.P. Petition Decision | 12 Feb, 2015 | US8470347 (Litigated) |
|
Mail-Petition Decision - Dismissed
Critical
| 10 Feb, 2015 | US8470347 (Litigated) |
Abbott's Family Patents
Clinical Trials
Recent Clinical Trials by Abbott:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | Abbott | NA |
COMPLETED
(Jan, 2016)
| PHASE3 |
| Creon in HIV Patients With Steatorrhea | Abbott | NA |
TERMINATED
(Jul, 2011)
| PHASE3 |
Abbott Drug List
Given below is the complete list of Abbott's drugs and the patents protecting them.
1. Hytrin
Hytrin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5294615 | Terazosin polymorph and pharmaceutical composition |
29 Apr, 2013
(12 years ago)
| Expired |
| US5412095 | Terazosin monohydrochloride and processes and intermediate for its production |
29 Apr, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hytrin's drug page
2. Meridia
Meridia is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5436272
(Pediatric)
| Treatment of obesity |
25 Jan, 2013
(13 years ago)
| Expired |
| US5436272 | Treatment of obesity |
25 Jul, 2012
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Meridia's drug page
3. Norvir
Norvir is protected by 8 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5648497
(Pediatric)
| Retroviral protease inhibiting compounds |
15 Jan, 2015
(11 years ago)
| Expired |
| US5635523
(Pediatric)
| Retroviral protease inhibiting compounds |
03 Dec, 2014
(11 years ago)
| Expired |
| US5648497 | Retroviral protease inhibiting compounds |
15 Jul, 2014
(11 years ago)
| Expired |
| US5635523 | Retroviral protease inhibiting compounds |
03 Jun, 2014
(11 years ago)
| Expired |
| US5948436
(Pediatric)
| Pharmaceutical composition |
13 Mar, 2014
(12 years ago)
| Expired |
| US5541206
(Pediatric)
| Retroviral protease inhibiting compounds |
30 Jan, 2014
(12 years ago)
| Expired |
| US5948436 | Pharmaceutical composition |
13 Sep, 2013
(12 years ago)
| Expired |
| US5541206 | Retroviral protease inhibiting compounds |
30 Jul, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norvir's drug page